image
HeartBeam, Inc. BEAT
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
Watchlist
$ 1.65
-2.37 %
$ 55.6 M
Market Cap
-2.26
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one BEAT stock under the worst case scenario is HIDDEN Compared to the current market price of 1.65 USD, HeartBeam, Inc. is HIDDEN

BEAT Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one BEAT stock under the base case scenario is HIDDEN Compared to the current market price of 1.65 USD, HeartBeam, Inc. is HIDDEN

BEAT Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one BEAT stock under the best case scenario is HIDDEN Compared to the current market price of 1.65 USD, HeartBeam, Inc. is HIDDEN

BEAT Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart BEAT

image
1M -20%
6M -35%
1Y -17%
3Y 13%
5Y -2439%
All
$3.4$3.4$3.2$3.2$3.0$3.0$2.8$2.8$2.6$2.6$2.4$2.4$2.2$2.2$2.0$2.0$1.8$1.8$1.6$1.615 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-19.9 M OPERATING INCOME
-29.86%
Growth Rates
1Year -29.86%
3Years -105.70%
5Years -132.30%
7Years -6.29%
10Years -10.58%
-19.4 M NET INCOME
-32.85%
Growth Rates
1Year -32.85%
3Years -63.77%
5Years -105.09%
7Years -2.87%
10Years -7.10%
-14.5 M OPERATING CASH FLOW
-19.66%
Growth Rates
1Year -19.66%
3Years -64.85%
5Years -131.42%
7Years -7.03%
10Years -10.20%
-201 K INVESTING CASH FLOW
21.48%
Growth Rates
1Year 21.48%
3Years 0.00%
5Years 0.00%
7Years 62.05%
10Years 38.71%
866 K FINANCING CASH FLOW
-96.54%
Growth Rates
1Year -96.54%
3Years -62.48%
5Years 33.27%
7Years -52.82%
10Years -25.26%
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-4.94 M OPERATING INCOME
2.47%
Growth Rates
1Year -29.86%
3Years -105.70%
5Years -132.30%
7Years -6.29%
10Years -10.58%
-4.91 M NET INCOME
1.45%
Growth Rates
1Year -32.85%
3Years -63.77%
5Years -105.09%
7Years -2.87%
10Years -7.10%
-4.15 M OPERATING CASH FLOW
-25.59%
Growth Rates
1Year -19.66%
3Years -64.85%
5Years -131.42%
7Years -7.03%
10Years -10.20%
0 INVESTING CASH FLOW
100.00%
Growth Rates
1Year 21.48%
3Years 0.00%
5Years 0.00%
7Years 62.05%
10Years 38.71%
761 K FINANCING CASH FLOW
3523.81%
Growth Rates
1Year -96.54%
3Years -62.48%
5Years 33.27%
7Years -52.82%
10Years -25.26%
Balance Sheet HeartBeam, Inc.
image
Current Assets 2.77 M
Cash & Short-Term Investments 2.38 M
Receivables 0
Other Current Assets 393 K
Non-Current Assets 506 K
Long-Term Investments 0
PP&E 450 K
Other Non-Current Assets 56 K
72.56 %12.00 %13.74 %Total Assets$3.3m
Current Liabilities 1.62 M
Accounts Payable 531 K
Short-Term Debt 0
Other Current Liabilities 1.09 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0
32.74 %67.26 %Total Liabilities$1.6m
EFFICIENCY
Earnings Waterfall HeartBeam, Inc.
image
Revenue 0
Cost Of Revenue 0
Gross Profit 0
Operating Expenses 19.9 M
Operating Income -19.9 M
Other Expenses -439 K
Net Income -19.4 M
00(2m)(2m)(4m)(4m)(6m)(6m)(8m)(8m)(10m)(10m)(12m)(12m)(14m)(14m)(16m)(16m)(18m)(18m)(20m)(20m)000(20m)(20m)439k(19m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
0.00% GROSS MARGIN
0.00%
Averages
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 8.96%
10Years 24.46%
0.00% OPERATING MARGIN
0.00%
Averages
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 3.00%
10Years 6.45%
0.00% NET MARGIN
0.00%
Averages
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 1.53%
10Years 3.50%
-1175.82% ROE
-1175.82%
Averages
1Year -1175.82%
3Years -602.66%
5Years -365.80%
7Years -256.33%
10Years -175.24%
-593.65% ROA
-593.65%
Averages
1Year -593.65%
3Years -332.23%
5Years -737.38%
7Years -2113.42%
10Years -1476.41%
-1202.36% ROIC
-1202.36%
Averages
1Year -1202.36%
3Years -613.88%
5Years -332.81%
7Years -215.50%
10Years -140.17%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis HeartBeam, Inc.
image
50m50m40m40m30m30m20m20m10m10m00(10m)(10m)(20m)(20m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -19.4 M
Depreciation & Amortization 7 K
Capital Expenditures -201 K
Stock-Based Compensation 4.3 M
Change in Working Capital 671 K
Others 243 K
Free Cash Flow -14.7 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets HeartBeam, Inc.
image
BEAT has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 6
6. Ownership
Insider Ownership HeartBeam, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
28 K USD 1
9-12 MONTHS
0 USD 0
Bought
80 K USD 2
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
HeartBeam, Inc. (BEAT) Q4 2024 Earnings Call Transcript HeartBeam, Inc. (NASDAQ:BEAT ) Q4 2024 Results Conference Call March 13, 2025 4:30 PM ET Company Participants Rob Eno - Chief Executive Officer Tim Cruickshank - Chief Financial Officer Operator Greetings, and welcome to the HeartBeam Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. seekingalpha.com - 1 month ago
HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025 SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 17-21, 2025. businesswire.com - 1 month ago
HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock. businesswire.com - 1 month ago
HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock. businesswire.com - 2 months ago
HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software. businesswire.com - 2 months ago
HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference. businesswire.com - 3 months ago
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology. businesswire.com - 4 months ago
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference. businesswire.com - 5 months ago
HeartBeam, Inc. (BEAT) Q3 2024 Earnings Call Transcript HeartBeam, Inc. (NASDAQ:BEAT ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Rob Eno - Chief Executive Officer Branislav Vajdic - President and Founder Tim Cruickshank - Chief Financial Officer Conference Call Participants Operator Greetings, and welcome to the HeartBeam Third Quarter 2024 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. seekingalpha.com - 5 months ago
HeartBeam Reports Third Quarter 2024 Results SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Third Quarter 2024 Results. businesswire.com - 5 months ago
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time. businesswire.com - 5 months ago
HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards. businesswire.com - 5 months ago
8. Profile Summary

HeartBeam, Inc. BEAT

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 55.6 M
Dividend Yield 0.00%
Description HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
Contact 2118 Walsh Avenue, Santa Clara, CA, 95050 https://www.heartbeam.com
IPO Date Nov. 11, 2021
Employees 21
Officers Dr. Branislav Vajdic Ph.D. Founder, President & Director Dr. Peter J. Fitzgerald FACC, M.D., Ph.D. Member of Scientific Advisory Board & Chief Medical Officer Mr. Kenneth Persen Chief Technology Officer Dr. Lance Myers Ph.D. Chief Artificial Intelligence Scientist Mr. Timothy Cruickshank Chief Financial Officer Mr. Robert P. Eno Chief Executive Officer & Chief Business Officer Ms. Richa Gujarati Senior Vice President of Product Mr. Richard M. Ferrari Executive Chairman